Abstract

Abstract Submission

The TRAC2025 Scientific Abstract Submission is now open and will close on the 31 July 2025 deadline.

Registration for the conference is mandatory for abstract submission.

Abstracts should be submitted through email and sent to sctrac2025@gmail.com along with your TRAC2025 Registration number.

For further details and queries contact:  Dr. RAMESH : +91 96266 11976

Abstract Submission Guidelines

It is not permitted to submit work that has been published and/or is likely to be published before the Abstract Submission Deadline (31 July 2025).The Programme Committee has the right to remove an abstract if it contains data that has already been published. However, TRAC2025 accepts the submission of abstracts that have been presented in recent months at local or national diabetes meetings.

Abstracts submitted on Human Studies

The box must be marked stating that the study has been reviewed by the Local Ethics Committee and that it has therefore been performed in accordance with the ethical standards laid down in the Helsinki Declaration

Abstracts submitted on Animal Studies

The box must be marked stating that the study has been carried out along the “Principles of laboratory animal care” (NIH Publication no. 85-23, revised 1985) and according to the national law, if applicable.

The abstract must be submitted as follows:

There is no limit to the number of abstracts an author may submit. however, an author may only serve as the presenting author on two submissions. It is the author’s responsibility to designate a new presenter for presentation scheduling conflicts that arise. If accepted, the presenter must be a co-author listed on the abstract at the time of submission.

The abstract must be submitted in English.

Your abstract submission must adhere to the following structure

  • The maximum number of characters is 3,200 (excl. spaces) including the title and the author block. The title should be short (maximum 170 characters).

  • The abstract must be structured. Enter each section into the corresponding text field with the provided sub-headings in bold (Background and aims, Materials and methods, Results and Conclusion).

  • For drugs exclusively generic names should be used (no trademarks).

  • Grant/Support information must be entered.

  • Where applicable, the Clinical Trial Registration Number must be entered into its designated field. not in the abstract body.

  • Registration for the conference is mandatory for abstract submission.

  • Abstracts should be submitted as an e-mail attachment along with their TRAC2025 Registration details.

Once all submission steps have been completed and the abstract deadline has passed, the presenting author will receive a notification in an email confirming the final version of the abstract submission.

In case of questions, or if you have not received a notification confirming the final version of the abstract submission by 31 July 2025, please contact the TRAC2025 office: sctrac2025@gmail.com

Email your Abstract to

sctrac2025@gmail.com